DHX58 and viral infectious disease: We have identified a distinct antiviral regulation for LGP2 completely different from the previous immune regulation of viral infection by regulating RLRs signaling pathway [19], affecting ubiquitination [39], protein interaction [58], and protein cleavage [30].